The FDA has proposed requiring makers of metal-on-metal hip implants to submit additional data to back the safety and effectiveness of their devices in order to continue marketing them. The move is spurred by concerns that the devices can lead to soft-tissue damage and may require replacement surgery.
FDA mulls subjecting metal hip implants to tougher oversight
SmartBrief Job Listings for Health Care
|Chief Financial Officer||
B. E. Smith
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|